EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitFallberichtOpen Access · CC BY 4.0

MSH4 and MSH5 variants in premature ovarian insufficiency: A literature review and case study

Jaidah Fergus-Mackie, Brianna L Kline, Gorjana Robevska, Jocelyn van den Bergen, Katrina Bell, Jérôme Dulon, Anna Lokchine, Philippe Touraine, Sylvie Jaillard, Wayne Crismani, Katie Ayers, Andrew Sinclair und 1 weitere

Maturitas · 2026-08 · 211 · 109034

DOI: 10.1016/j.maturitas.2026.109034 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Maturitas, 2026-08. Verfasst von Jaidah Fergus-Mackie und 12 weiteren Autor:innen. Beteiligte Einrichtung: Murdoch Children's Research Institute, Melbourne, VIC, Australia; Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia. Elec…. Hauptthemen laut MEDLINE: Primary Ovarian Insufficiency, MutS Proteins, DNA-Binding Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cybec Foundation, National Health and Medical Research Council, Veski.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Premature ovarian insufficiency (POI) affects up to 4% of women under 40 years, with genetic factors implicated in a substantial proportion of cases. MSH4 and MSH5 encode components of the MutSγ complex, which stabilises Holliday junctions during meiotic recombination. This review examines the evidence for MSH4 and MSH5 involvement in POI. Biallelic MSH4 variants are well-established causes of POI and non-obstructive azoospermia (NOA), with MSH4 recognised as a high-evidence gene on clinical panels. MSH5 variants have similarly been reported in POI and NOA, though many lack functional validation. Affected individuals predominantly present with secondary amenorrhoea, with emerging evidence for milder phenotypes, including diminished ovarian reserve (DOR). Pathogenic variants are typically loss-of-function and/or disrupt conserved functional domains essential for meiotic recombination, in particular the C-terminal ATPase domain found in both MSH4 and MSH5. We also describe two homozygous MSH5 variants not previously reported in POI, identified in our patient cohort. Given the frequent later onset of POI associated with MSH4/MSH5 variants, there are significant implications for cascade screening, enabling predictive genetic testing in at-risk family members.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Primary Ovarian InsufficiencyMutS ProteinsDNA-Binding ProteinsHumansFemaleAzoospermiaCell Cycle Proteins

Stichwörter der Autor:innen

Diminished ovarian reserveHomologous recombinationMSH4MSH5Meiotic recombinationMutSγ complexNon-obstructive azoospermiaPremature ovarian failurePremature ovarian insufficiencySecondary amenorrhoeaVariant curation

Substanzen

MSH5 protein, humanMSH4 protein, humanMutS ProteinsDNA-Binding ProteinsCell Cycle Proteins

Autor:innen und Institutionen

  • Murdoch Children's Research Institute, Melbourne, VIC, Australia; Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia. Electronic address: jaidah.fergusmackie@mcri.edu.au.
  • Murdoch Children's Research Institute, Melbourne, VIC, Australia; Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia.
  • Murdoch Children's Research Institute, Melbourne, VIC, Australia.
  • Department of Endocrinology and Reproductive Medicine, AP-HP, Sorbonne University, France.
  • Univ Rennes, CHU Rennes, Inserm, Irset (institut de recherche en santé, environnement et travail) - UMR_S 1085, service de Cytogénétique et Biologie Cellulaire, F-35000, Rennes, France.
  • DNA Repair and Recombination Laboratory, St. Vincent's Institute of Medical Research, Fitzroy, VIC, Australia; The Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Victoria, Australia.

Förderung

  • Cybec Foundation
  • National Health and Medical Research Council
  • Veski
  • Norman Beischer Medical Research Foundation
  • Murdoch Children's Research Institute
  • Victorian Cancer Agency

Zitieren

APA

Fergus-Mackie, J., Kline, B. L., Robevska, G., van den Bergen, J., Bell, K., Dulon, J., Lokchine, A., Touraine, P., Jaillard, S., Crismani, W., Ayers, K., Sinclair, A., & Tucker, E. J. (2026). MSH4 and MSH5 variants in premature ovarian insufficiency: A literature review and case study. Maturitas, 211, 109034. https://doi.org/10.1016/j.maturitas.2026.109034

Vancouver

Fergus-Mackie J, Kline BL, Robevska G, van den Bergen J, Bell K, Dulon J, et al. MSH4 and MSH5 variants in premature ovarian insufficiency: A literature review and case study. Maturitas. 2026;211:109034. doi:10.1016/j.maturitas.2026.109034

BibTeX
@article{FergusMackie2026,
  author = {Fergus-Mackie, Jaidah and Kline, Brianna L and Robevska, Gorjana and van den Bergen, Jocelyn and Bell, Katrina and Dulon, Jérôme and Lokchine, Anna and Touraine, Philippe and Jaillard, Sylvie and Crismani, Wayne and Ayers, Katie and Sinclair, Andrew and Tucker, Elena J},
  title = {MSH4 and MSH5 variants in premature ovarian insufficiency: A literature review and case study},
  journal = {Maturitas},
  year = {2026},
  volume = {211},
  pages = {109034},
  doi = {10.1016/j.maturitas.2026.109034}
}
Kostenlos starten →